Literature DB >> 17005003

Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gamma.

Ana Paula Junqueira-Kipnis1, Randall J Basaraba, Veronica Gruppo, Gopinath Palanisamy, Oliver C Turner, Tsungda Hsu, William R Jacobs, Scott A Fulton, Scott M Reba, W Henry Boom, Ian M Orme.   

Abstract

The genetic region of difference 1 (RD1) in Mycobacterium tuberculosis has recently been hypothesized to encode for proteins that are cytotoxic to the host cell in nature. We demonstrate here that while M. tuberculosis grew progressively in the lungs of gene disrupted mice (GKO) unable to produce interferon-gamma (IFN-gamma), similar mice infected instead with M. bovis bacillus Calmette-Guérin (BCG) reproducibly exhibited an obvious slowing of the disease after about 20 days. Closer examination of BCG-infected GKO mice showed a florid granulomatous inflammation in the lungs, whereas similar mice infected with M. tuberculosis exhibited wholesale progressive necrosis. In the BCG-infected GKO mice large numbers of activated effector T cells, some strongly positive for the cytokine tumour necrosis factor, as well as activated natural killer cells accumulated in the lungs. To further test the hypothesis that the differences observed were directly associated with the loss of the RD1 region, it was then shown that a mutant of M. tuberculosis lacking RD1 grew progressively in both normal and GKO mice but failed to induce any degree of necrosis in either animal despite reaching similar levels in the lungs. However, when mice were infected with this mutant, in which the RD1 region had been restored by complementation, wholesale necrosis of the lungs again occurred. These data support the hypothesis that proteins encoded in the RD1 region are a major cause of necrosis and contribute significantly to the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005003      PMCID: PMC1782352          DOI: 10.1111/j.1365-2567.2006.02427.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

Review 1.  Beyond BCG: the potential for a more effective TB vaccine.

Authors:  I M Orme
Journal:  Mol Med Today       Date:  1999-11

Review 2.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 3.  Comparative genomics of BCG vaccines.

Authors:  M A Behr
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

4.  Human macrophage gamma interferon decreases gene expression but not replication of Mycobacterium tuberculosis: analysis of the host-pathogen reciprocal influence on transcription in a comparison of strains H37Rv and CMT97.

Authors:  G Cappelli; P Volpe; A Sanduzzi; A Sacchi; V Colizzi; F Mariani
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

Authors:  C Dye; S Scheele; P Dolin; V Pathania; M C Raviglione
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

6.  Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse.

Authors:  Gary M Winslow; Alan D Roberts; Marcia A Blackman; David L Woodland
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

7.  The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.

Authors:  Tsungda Hsu; Suzanne M Hingley-Wilson; Bing Chen; Mei Chen; Annie Z Dai; Paul M Morin; Carolyn B Marks; Jeevan Padiyar; Celia Goulding; Mari Gingery; David Eisenberg; Robert G Russell; Steven C Derrick; Frank M Collins; Sheldon L Morris; C Harold King; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

8.  CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

9.  Interferon-gamma receptor-1 gene polymorphism in tuberculosis patients from Croatia.

Authors:  D A Fraser; L Bulat-Kardum; J Knezevic; P Babarovic; N Matakovic-Mileusnic; J Dellacasagrande; D Matanic; J Pavelic; Z Beg-Zec; Z Dembic
Journal:  Scand J Immunol       Date:  2003-05       Impact factor: 3.487

10.  Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.

Authors:  Kaeryn N Lewis; Reiling Liao; Kristi M Guinn; Mark J Hickey; Sherilyn Smith; Marcel A Behr; David R Sherman
Journal:  J Infect Dis       Date:  2002-12-02       Impact factor: 5.226

View more
  16 in total

Review 1.  Immune regulatory activities of early secreted antigenic target of 6-kD protein of Mycobacterium tuberculosis and implications for tuberculosis vaccine design.

Authors:  Buka Samten; Xisheng Wang; Peter F Barnes
Journal:  Tuberculosis (Edinb)       Date:  2011-12-09       Impact factor: 3.131

2.  Mycobacterium marinum down-regulates miR-148a in macrophages in an EsxA-dependent manner.

Authors:  Haichong Wu; Yanqing Bao; Lin Wang; Xiujun Li; Jianjun Sun
Journal:  Int Immunopharmacol       Date:  2019-05-09       Impact factor: 4.932

3.  Acute immune response to Mycobacterium massiliense in C57BL/6 and BALB/c mice.

Authors:  Eduardo Martins de Sousa; Fernando Bonfim de Bortoli; Eduardo Pinheiro Amaral; Aline Carvalho Batista; Thereza Liberman Kipnis; Alessandra Marques Cardoso; André Kipnis; Ana Paula Junqueira-Kipnis
Journal:  Infect Immun       Date:  2010-02-01       Impact factor: 3.441

4.  Potential role for ESAT6 in dissemination of M. tuberculosis via human lung epithelial cells.

Authors:  Arvind G Kinhikar; Indu Verma; Dinesh Chandra; Krishna K Singh; Karin Weldingh; Peter Andersen; Tsungda Hsu; William R Jacobs; Suman Laal
Journal:  Mol Microbiol       Date:  2009-11-10       Impact factor: 3.501

5.  Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from the vacuole.

Authors:  Jennifer Smith; Joanna Manoranjan; Miao Pan; Amro Bohsali; Junjie Xu; Jun Liu; Kent L McDonald; Agnieszka Szyk; Nicole LaRonde-LeBlanc; Lian-Yong Gao
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

6.  Contrasting transcriptional responses of a virulent and an attenuated strain of Mycobacterium tuberculosis infecting macrophages.

Authors:  Alice H Li; Simon J Waddell; Jason Hinds; Chad A Malloff; Manjeet Bains; Robert E Hancock; Wan L Lam; Philip D Butcher; Richard W Stokes
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

7.  ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity.

Authors:  Marien I de Jonge; Gérard Pehau-Arnaudet; Marjan M Fretz; Felix Romain; Daria Bottai; Priscille Brodin; Nadine Honoré; Gilles Marchal; Wim Jiskoot; Patrick England; Stewart T Cole; Roland Brosch
Journal:  J Bacteriol       Date:  2007-06-08       Impact factor: 3.490

8.  Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model.

Authors:  Gopinath S Palanisamy; Erin E Smith; Crystal A Shanley; Diane J Ordway; Ian M Orme; Randall J Basaraba
Journal:  Tuberculosis (Edinb)       Date:  2008-03-05       Impact factor: 3.131

9.  MyBASE: a database for genome polymorphism and gene function studies of Mycobacterium.

Authors:  Xinxing Zhu; Suhua Chang; Kechi Fang; Sijia Cui; Jun Liu; Zuowei Wu; Xuping Yu; George F Gao; Huanming Yang; Baoli Zhu; Jing Wang
Journal:  BMC Microbiol       Date:  2009-02-20       Impact factor: 3.605

10.  Mycobacterium tuberculosis subverts the TLR-2-MyD88 pathway to facilitate its translocation into the cytosol.

Authors:  Aejazur Rahman; Parveen Sobia; Neeta Gupta; Luc Van Kaer; Gobardhan Das
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.